Do you want to skip to content? Skip to content
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本
Convatec

Most visited pages

Reports, results and presentations
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本

Download Full Press Release

PDF Download

 

Convatec Group Plc ("Convatec”), a leading global medical products and technologies company has partnered with the European Wound Management Association (EWMA) to launch three research grants available to Nurses, Doctors or Scientists working in the field of wound management.

The new initiative was launched at the 29th European Wound Management Association Conference in Gothenburg on 5th June with the aim to offer support to projects that advance the basic and clinical science of wound management. By advancing research and supporting innovation, EWMA and Convatec aim to improve the care and quality of life of individuals with acute and chronic wounds. Convatec’s contribution of €30,000 will be split across three themes; Process redesign to improve quality and accessibility in wound care, E-health and digital solutions for wound management and Solutions to enhance patient safety and compliance in wound management. A wide range of applications are expected across Europe with the winners of the research grants announced at the EWMA 2020 conference in London.

David Shepherd – President Advanced Wound Care, Convatec said:

”Convatec is committed to working with wound management professionals to improve the lives of people with chronic conditions. In a challenging economic climate where health care systems and budgets are squeezed and the demands upon clinicians increase, it is critical that we invest in further education to support clinicians in better dealing with the challenges they face. This exciting new initiative led by EWMA and exclusively sponsored by Convatec offers three individuals the opportunity to study three specific subject areas which we believe will play a big part of the future in wound management.”

Alberto Piaggesi, EWMA Scientific Recorder and President Elect added:

“It is one of EWMA's priorities to promote innovative projects that provide new knowledge and perspectives on the field of wound management. It is of huge importance for EWMA to secure the future of wound management and support new talents in the wound community. EWMA research grants is a timely initiative that aims to make a difference for wound management research and improve the quality of life for the increasing number of patients suffering from acute and chronic wounds throughout Europe”.

 

Enquiries

 
Analysts and Investors 
                                                                                                                     

investorrelations@convatec.com

John Crosse, VP Investor Relations

+44 (0)7500 141435

Mark Reynolds, Director Investor Relations

+44 (0)7551 036625


Media


mediarelations@convatec.com

Bobby Leach, VP Group Corporate Affairs                      

+44 (0)7770 842226

Finsbury

+44 (0)207 2513801

 

About Convatec

Convatec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Convatec’s products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.

Press Release

See all

5/13/2022

5/13/2022

Convatec Group Plc Annual Results 2018

Convatec Group Plc Annual Results 2018

Read more

5/13/2022

5/13/2022

2018 Annual Report & Accounts

2018 Annual Report & Accounts

Read more

5/13/2022

5/13/2022

Appointment of Chief Executive Officer

Appointment of Chief Executive Officer

Read more

5/13/2022

5/13/2022

Board Changes

Board Changes

Read more

5/13/2022

5/13/2022

Results of Annual General Meeting

Results of Annual General Meeting

Read more

5/13/2022

5/13/2022

Convatec partners with EWMA to support Research Grants in 2019

Convatec partners with EWMA to support Research Grants in 2019

Read more

5/13/2022

5/13/2022

Board Change

Board Change

Read more

5/13/2022

5/13/2022

Beta Bionics and Convatec announce partnership to bring Unomedical infusion set portfolio to the iLet™ Bionic Pancreas System

Beta Bionics and Convatec announce partnership to bring Unomedical infusion set portfolio to the iLet™ Bionic Pancreas System

Read more

5/13/2022

5/13/2022

Convatec Group Plc First Half Results 2019

Convatec Group Plc First Half Results 2019

Read more

5/13/2022

5/13/2022

John McAdam appointed Chairman of Convatec

John McAdam appointed Chairman of Convatec

Read more

5/13/2022

5/13/2022

Acquisition of Southlake Medical Supplies

Acquisition of Southlake Medical Supplies

Read more

5/13/2022

5/13/2022

Trading Update for the three months ended 30 September 2019

Trading Update for the three months ended 30 September 2019

Read more